Percutaneous transluminal angioplasty of internal carotid artery: a preliminary report of seesaw balloon technique. 1993

A Kinoshita, and M Itoh, and O Takemoto
Department of Neurosurgery, Osaka University Medical School, Japan.

Percutaneous transluminal angioplasty (PTA) has become a common neurosurgical procedure. This technique, however, has been rarely used for stenosis of the internal carotid artery because of the resultant embolization with debris following balloon manipulation. We present a case of internal carotid artery stenosis with a complaint of transient mono-ocular blindedness, whose ischaemic attack was relieved by PTA operation. In this case, we applied endovascular treatment for carotid stenosis, known as 'seesaw balloon technique', which prevented cerebral embolization with debris from the lesion. This technique may simplify the endovascular treatment for distally located carotid stenosis and shorten the operation time.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002343 Carotid Artery, Internal Branch of the common carotid artery which supplies the anterior part of the brain, the eye and its appendages, the forehead and nose. Arteries, Internal Carotid,Artery, Internal Carotid,Carotid Arteries, Internal,Internal Carotid Arteries,Internal Carotid Artery
D002542 Intracranial Embolism and Thrombosis Embolism or thrombosis involving blood vessels which supply intracranial structures. Emboli may originate from extracranial or intracranial sources. Thrombosis may occur in arterial or venous structures. Brain Embolism and Thrombosis,Cerebral Embolism and Thrombosis,Embolism and Thrombosis, Brain
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000800 Angioplasty, Balloon Use of a balloon catheter for dilation of an occluded artery. It is used in treatment of arterial occlusive diseases, including renal artery stenosis and arterial occlusions in the leg. For the specific technique of BALLOON DILATION in coronary arteries, ANGIOPLASTY, BALLOON, CORONARY is available. Balloon Angioplasty,Dilation, Transluminal Arterial,Arterial Dilation, Transluminal,Arterial Dilations, Transluminal,Dilations, Transluminal Arterial,Transluminal Arterial Dilation,Transluminal Arterial Dilations
D013988 Ticlopidine An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES. 53-32C,Ticlid,Ticlodix,Ticlodone,Ticlopidine Hydrochloride,53 32C,5332C,Hydrochloride, Ticlopidine
D014786 Vision Disorders Visual impairments limiting one or more of the basic functions of the eye: visual acuity, dark adaptation, color vision, or peripheral vision. These may result from EYE DISEASES; OPTIC NERVE DISEASES; VISUAL PATHWAY diseases; OCCIPITAL LOBE diseases; OCULAR MOTILITY DISORDERS; and other conditions (From Newell, Ophthalmology: Principles and Concepts, 7th ed, p132). Hemeralopia,Macropsia,Micropsia,Day Blindness,Metamorphopsia,Vision Disability,Visual Disorders,Visual Impairment,Blindness, Day,Disabilities, Vision,Disability, Vision,Disorder, Visual,Disorders, Visual,Hemeralopias,Impairment, Visual,Impairments, Visual,Macropsias,Metamorphopsias,Micropsias,Vision Disabilities,Vision Disorder,Visual Disorder,Visual Impairments

Related Publications

A Kinoshita, and M Itoh, and O Takemoto
January 1982, AJNR. American journal of neuroradiology,
A Kinoshita, and M Itoh, and O Takemoto
May 1997, The British journal of surgery,
A Kinoshita, and M Itoh, and O Takemoto
May 1997, The British journal of surgery,
A Kinoshita, and M Itoh, and O Takemoto
September 1996, The British journal of surgery,
A Kinoshita, and M Itoh, and O Takemoto
March 1993, No shinkei geka. Neurological surgery,
A Kinoshita, and M Itoh, and O Takemoto
January 1983, AJNR. American journal of neuroradiology,
A Kinoshita, and M Itoh, and O Takemoto
September 2012, The Cochrane database of systematic reviews,
A Kinoshita, and M Itoh, and O Takemoto
May 1981, AJR. American journal of roentgenology,
A Kinoshita, and M Itoh, and O Takemoto
March 2002, No shinkei geka. Neurological surgery,
A Kinoshita, and M Itoh, and O Takemoto
November 1998, Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences,
Copied contents to your clipboard!